Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up

Neurology. 2003 Jan 14;60(1):154-5; author reply 154-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Confusion / etiology
  • Depression / chemically induced
  • Dopamine Agonists / adverse effects*
  • Dopamine Agonists / therapeutic use
  • Electric Stimulation Therapy*
  • Follow-Up Studies
  • Levodopa / adverse effects*
  • Levodopa / therapeutic use
  • Mood Disorders / etiology
  • Neuroleptic Malignant Syndrome / prevention & control
  • Parkinson Disease / therapy*
  • Quality of Life
  • Social Behavior Disorders / chemically induced
  • Substance Withdrawal Syndrome / etiology
  • Subthalamic Nucleus* / physiology
  • Time
  • Treatment Outcome

Substances

  • Dopamine Agonists
  • Levodopa